A
Annemieke De Wilde
Researcher at University of Antwerp
Publications - 11
Citations - 405
Annemieke De Wilde is an academic researcher from University of Antwerp. The author has contributed to research in topics: Biobank & Population. The author has an hindex of 7, co-authored 11 publications receiving 338 citations.
Papers
More filters
Journal ArticleDOI
Standard Preanalytical Coding for Biospecimens: Review and Implementation of the Sample PREanalytical Code (SPREC)
Sabine Lehmann,Fiorella Guadagni,Helen M. Moore,Garry Ashton,Michael R. Barnes,Erica E. Benson,Judith A. Clements,Iren Koppandi,Domenico Coppola,Sara Yasemin Demiroglu,Yvonne DeSouza,Annemieke De Wilde,Jacko Duker,James Eliason,Barbara Glazer,Keith G Harding,Jae Pil Jeon,Joseph Kessler,Theresa J. Kokkat,Umberto Nanni,Kathi Shea,Amy P.N. Skubitz,Stella Somiari,Gunnel Tybring,Elaine W. Gunter,Fotini Betsou +25 more
TL;DR: The first version of the Standard PREanalytical Code (SPREC) was developed in 2009 by the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group to facilitate documentation and communication of the most important preanalytical quality parameters of different types of biospecimens used for research.
Journal ArticleDOI
Cachexia in cancer: what is in the definition?
Greetje Vanhoutte,Mick van de Wiel,Kristin Wouters,Michaël Sels,Linda Bartolomeeussen,Sven De Keersmaecker,Caroline Verschueren,Veronique De Vroey,Annemieke De Wilde,Elke Smits,Kin Jip Cheung,Liesbeth De Clerck,Petra Aerts,Didier Baert,Caroline Vandoninck,Sofie Kindt,Sofie Schelfhaut,Marc Vankerkhoven,Annelies Troch,Lore Ceulemans,Hanne Vandenbergh,Sven Leys,Tim Rondou,Elke Dewitte,Kristel Maes,Patrick Pauwels,Benedicte Y. De Winter,Luc Van Gaal,Dirk Ysebaert,Marc Peeters +29 more
TL;DR: A correlation with prognosis in favour of Evans et al’ definition as a tool for cachexia diagnosis is presented, which means that weight loss and BMI decline are both key factors in patients with cancer leading to cachexia but less decisive as stated by Fearon et al.
Journal ArticleDOI
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it
Christian Rolfo,Francesco Passiglia,Marta Castiglia,Luis E. Raez,Paul Germonpré,Ignacio Gil-Bazo,Karen Zwaenepoel,Annemieke De Wilde,Giuseppe Bronte,Antonio Russo,Jan P. van Meerbeeck,Paul Van Schil,Patrick Pauwels +12 more
TL;DR: Pre-clinical data and early clinical trials showed the promising efficacy of a new class of ALK-inhibitors in overcoming acquired resistance, and the inhibition of the molecular chaperone, HSP90, represents another promising strategy to overcome crizotinib resistance in AlK-rearranged NSCLC.
Journal ArticleDOI
Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group
Fay Betsou,Alexandre Bulla,Sang Yun Cho,Judith A. Clements,Rodrigo F. Chuaqui,Domenico Coppola,Yvonne De Souza,Annemieke De Wilde,William E. Grizzle,Fiorella Guadagni,Elaine W. Gunter,Stacey Heil,Verity S. Hodgkinson,Joseph Kessler,Michael Kiehntopf,Hee Sung Kim,Iren Koppandi,Katheryn Shea,Rajeev Singh,Marc Sobel,Stella Somiari,Demetri D. Spyropoulos,Mars Stone,Gunnel Tybring,Klara Valyi-Nagy,Gert Van den Eynden,Lalita Wadhwa +26 more
TL;DR: Quality control (QC) assays that can be performed in order to qualify clinical biospecimens that have been biobanked for use in research are presented.
Journal ArticleDOI
A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience
Amélie Gaignaux,Garry Ashton,Domenico Coppola,Yvonne De Souza,Annemieke De Wilde,James Eliason,William E. Grizzle,Fiorella Guadagni,Elaine W. Gunter,Iren Koppandi,Katheryn Shea,Tim Shi,Julie A. Stein,Mark E. Sobel,Gunnel Tybring,Gert Van den Eynden,Gert Van den Eynden,Fay Betsou +17 more
TL;DR: An international PT program has been developed and provided to biobanks and other laboratories that perform specific tests to qualify different types of biospecimens, and supports the development of biobank quality assurance by providing the possibility to assess biobanking laboratory performance and useful insights into biob bank laboratory method performance characteristics and thus fulfill the demands from accreditation authorities.